Small cell lung cancer is not associated with the presence of anti-fucosyl-GM1 ganglioside autoantibodies reactive in immunoenzymatic test. 2001

G Adler, and T Pacuszka, and A Lewartowska, and E Rowinska, and P Oblakowski, and M Panasiewicz
Department of Biochemistry, Medical Center of Postgraduate Education, Marymoncka 99, 01 813 Warsaw, Poland. grad@cmkp.edu.pl

The characteristic feature of small cell lung cancer carcinoma (SCLC) is the aberrant expression and abundant presentation of fucosyl-GM1 ganglioside (FucGM1). In the present study we searched for the presence of anti-FucGM1 ganglioside, as well as anti-GM1, GM2 and GD3 ganglioside autoantibodies in the sera of patients with SCLC and as a control, in sera of patients with renal cell cancer (RC) and healthy blood donors. The autoantibodies against FucGM1 were present at low titer in only three of 36 SCLC patients, and with similar titer in two of 36 RC patients and four of 36 healthy controls. Likewise, the autoantibodies against GM2 and GM3 gangliosides were found only sporadically and with the same titer and frequency in cancer patients as in healthy persons. Anti-GD3 autoantibodies could not be detected in any of the screened sera.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005677 G(M1) Ganglioside A specific monosialoganglioside that accumulates abnormally within the nervous system due to a deficiency of GM1-b-galactosidase, resulting in GM1 gangliosidosis. GM1 Ganglioside,Monosialosyl Tetraglycosyl Ceramide,GM1a Monosialoganglioside,Ceramide, Monosialosyl Tetraglycosyl,Ganglioside, GM1,Monosialoganglioside, GM1a,Tetraglycosyl Ceramide, Monosialosyl
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody

Related Publications

G Adler, and T Pacuszka, and A Lewartowska, and E Rowinska, and P Oblakowski, and M Panasiewicz
January 1994, Cancer detection and prevention,
G Adler, and T Pacuszka, and A Lewartowska, and E Rowinska, and P Oblakowski, and M Panasiewicz
December 1991, International journal of cancer,
G Adler, and T Pacuszka, and A Lewartowska, and E Rowinska, and P Oblakowski, and M Panasiewicz
March 1986, Cancer research,
G Adler, and T Pacuszka, and A Lewartowska, and E Rowinska, and P Oblakowski, and M Panasiewicz
January 1993, Acta oncologica (Stockholm, Sweden),
G Adler, and T Pacuszka, and A Lewartowska, and E Rowinska, and P Oblakowski, and M Panasiewicz
December 1992, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
G Adler, and T Pacuszka, and A Lewartowska, and E Rowinska, and P Oblakowski, and M Panasiewicz
October 2006, Glycobiology,
G Adler, and T Pacuszka, and A Lewartowska, and E Rowinska, and P Oblakowski, and M Panasiewicz
March 1989, Cancer research,
G Adler, and T Pacuszka, and A Lewartowska, and E Rowinska, and P Oblakowski, and M Panasiewicz
September 1994, Annals of oncology : official journal of the European Society for Medical Oncology,
G Adler, and T Pacuszka, and A Lewartowska, and E Rowinska, and P Oblakowski, and M Panasiewicz
October 1999, Clinical cancer research : an official journal of the American Association for Cancer Research,
G Adler, and T Pacuszka, and A Lewartowska, and E Rowinska, and P Oblakowski, and M Panasiewicz
November 1994, Journal of biochemistry,
Copied contents to your clipboard!